Deciphera Pharmaceuticals LLC   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Waltham MA United States (2003)

Organization Overview

First Clinical Trial
2009
NCT00827138
First Marketed Drug
2020
ripretinib
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Deciphera Pharmaceuticals LLC | DECIPHERA PHARMACEUTICALS LLC | DECIPHERA PHARMS